论著
ENGLISH ABSTRACT
4 276例垂体瘤的回顾性临床分析
李一君
谷伟军
王岳鹏
吕朝晖
母义明
作者及单位信息
·
DOI: 10.3760/cma.j.cn121383-20211110-11036
Pituitary adenoma: retrospective clinical analysis of 4 276 cases
Li Yijun
Gu Weijun
Wang Yuepeng
Lyu Zhaohui
Mu Yiming
Authors Info & Affiliations
Li Yijun
Department of Endocrinology, the First Medical Centre of PLA General Hospital, Beijing 100853, China
Gu Weijun
Department of Endocrinology, the First Medical Centre of PLA General Hospital, Beijing 100853, China
Wang Yuepeng
Department of Endocrinology, the First Medical Centre of PLA General Hospital, Beijing 100853, China
School of Medicine, Nankai University, Tianjin 300071, China
Lyu Zhaohui
Department of Endocrinology, the First Medical Centre of PLA General Hospital, Beijing 100853, China
Mu Yiming
Department of Endocrinology, the First Medical Centre of PLA General Hospital, Beijing 100853, China
·
DOI: 10.3760/cma.j.cn121383-20211110-11036
1392
249
0
0
12
1
PDF下载
APP内阅读
摘要

目的总结不同激素分泌类型垂体瘤患者人群分布及临床特征,分析近16年垂体瘤疾病谱变化,指导临床诊疗。

方法收集2005年1月1日至2020年12月31日在解放军总医院第一医学中心首次住院诊疗的4 276例垂体瘤患者的病例资料,包括性别、年龄、入院日期、临床诊断、是否手术、术后病理诊断等,对其进行回顾性分析。

结果(1)16年间就诊于解放军总医院第一医学中心的垂体瘤患者共4 276例,其中男性1 871例(占比43.76%),女性2 405例(占比56.24%),平均就诊年龄(44.1±13.9)岁。(2)垂体瘤以无功能瘤(占比60.67%)、泌乳素瘤(16.10%)、生长激素瘤(13.93%)居多,无功能瘤多集中于41~60岁人群,泌乳素瘤、生长激素瘤多集中于21~40岁人群。(3)随时间进展,垂体瘤患者住院例数呈现逐步增加的趋势,高峰出现在2012年,垂体生长激素瘤及垂体促肾上腺皮质激素瘤患者占比呈现逐年增加趋势,而无功能瘤患者占比呈现下降趋势。

结论垂体无功能瘤、泌乳素瘤、生长激素瘤仍是临床最常见的3种垂体瘤,住院垂体无功能瘤病例占比随时间进展呈现逐步下降趋势。

垂体瘤;临床特征;激素分泌类型
ABSTRACT

ObjectiveTo summarize the distribution and clinical characteristics of patients with pituitary adenoma of different hormone secreting types, analyze the changes of the disease spectrum and to guide clinical diagnosis and treatment.

MethodsAll clinical data of patients with pituitary adenoma hospitalized in the First Medical Center of PLA General Hospital from Jan.1st 2005 to Dec.31rd 2020 were collected. The profile of gender ratio, age, date of admission, clinical diagnosis were retrospectively analyzed.

ResultsA total of 4 276 patients with pituitary adenoma were treated during 16 years, including 1 871 males (43.8%) and 2 405 females (56.2%) with the average age of consultation was (44.1±13.9) years. Non-functioning adenoma (60.7%), prolactinoma (16.1%) and growth hormone adenoma (13.9%) were at relatively high proportion. The visiting age of non-functioning adenoma was mostly concentrated between 41~60 years, and prolactinoma and growth hormone adenoma were mostly concentrated between 21~40 years. The number of patients with pituitary adenoma gradually increased with a peak in 2012, while the proportion of patients with growth hormone adenoma and adrenocorticotropic hormone adenoma increased and the proportion of patients with non-functional adenoma decreased slightly.

ConclusionNon-functional pituitary adenoma, prolactinoma, and growth hormone adenoma are still the most common pituitary adenoma in clinical practice. The proportion of hospitalized non-functional pituitary adenoma showes a gradual decline over time.

Pituitary adenoma;Clinical characteristics;Hormone-secreting type
Gu Weijun, Email: mocdef.3ab61103nujiewug
引用本文

李一君,谷伟军,王岳鹏,等. 4 276例垂体瘤的回顾性临床分析[J]. 国际内分泌代谢杂志,2022,42(01):7-11.

DOI:10.3760/cma.j.cn121383-20211110-11036

PERMISSIONS

Request permissions for this article from CCC.

评价本文
*以上评分为匿名评价
垂体瘤是颅内常见的肿瘤之一。根据肿瘤大小、是否分泌激素、是否侵袭性生长等临床特征可以对垂体瘤进行不同的分类。临床通常采用激素分泌类型对垂体瘤进行分类诊断,进而确定后续治疗方案。近年随着影像学技术的发展,人们健康意识的提高和体检的普及,垂体瘤,尤其是无功能瘤的检出率也逐年增多。了解垂体瘤疾病谱的变化及人群分布特征,有助于垂体瘤患者的临床诊治。本研究通过回顾性分析近16年中国人民解放军总医院第一医学中心垂体瘤患者的病例资料,总结该中心住院垂体瘤患者病种分布特点及疾病谱变化,为临床诊治提供一定的参考依据。
试读结束,您可以通过登录机构账户或个人账户后获取全文阅读权限。
参考文献
[1]
Ostrom QT , Patil N , Cioffi G et al. CBTRUS statistical report:primary brain and other central nervous system tumors diagnosed in the united states in 2013-2017[J]Neuro Oncol 202022(12Suppl 2):iv1-iv96. DOI: 10.1093/neuonc/noaa200 .
返回引文位置Google Scholar
百度学术
万方数据
[2]
Theodros D , Patel M , Ruzevick J et al. Pituitary adenomas:historical perspective,surgical management and future directions[J]CNS Oncol 20154(6):411-429. DOI: 10.2217/cns.15.21 .
返回引文位置Google Scholar
百度学术
万方数据
[3]
张奇志周印亭汪莹. 2010年-2018年1011例垂体瘤患者临床资料分析[J]世界最新医学信息文摘 202020(12):185-186. DOI: 10.3969/j.issn.1671-3141.2020.12.120 .
返回引文位置Google Scholar
百度学术
万方数据
[4]
陈来照马景鑑郑安潮. 128例垂体腺瘤回顾性分析[J]山西医科大学学报 200536(4):486-489. DOI: 10.3969/j.issn.1007-6611.2005.04.036 .
返回引文位置Google Scholar
百度学术
万方数据
[5]
陈汉文孙冰孙海玲. 287例垂体瘤患者临床特征分析及垂体功能评估[J]中华实用诊断与治疗杂志 201731(4):364-367. DOI: 10.13507/j.issn.1674-3474.2017.04.015 .
返回引文位置Google Scholar
百度学术
万方数据
[6]
初曙光沈天真陈星荣不同激素分泌类型垂体腺瘤的临床特点及MRI征象分析(附200例报告)[J]实用放射学杂志 200218(9):737-739. DOI: 10.3969/j.issn.1002-1671.2002.09.001 .
返回引文位置Google Scholar
百度学术
万方数据
[7]
Casanueva FF , Molitch ME , Schlechte JA et al. Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas[J]Clin Endocrinol(Oxf) 200665(2):265-273. DOI: 10.1111/j.1365-2265.2006.02562.x .
返回引文位置Google Scholar
百度学术
万方数据
[8]
Boscaro M , Barzon L , Fallo F et al. Cushing′s syndrome[J]Lancet 2001357(9258):783-791. DOI: 10.1016/S0140-6736(00)04172-6 .
返回引文位置Google Scholar
百度学术
万方数据
[9]
Arasho BD , Schaller B , Sandu N et al. Gender-related differences in pituitary adenomas[J]Exp Clin Endocrinol Diabetes 2009117(10):567-572. DOI: 10.1055/s-0029-1202831 .
返回引文位置Google Scholar
百度学术
万方数据
[10]
Tjörnstrand A , Gunnarsson K , Evert M et al. The incidence rate of pituitary adenomas in western Sweden for the period 2001-2011[J]Eur J Endocrinol 2014171(4):519-526. DOI: 10.1530/EJE-14-0144 .
返回引文位置Google Scholar
百度学术
万方数据
[11]
Dolecek TA , Propp JM , Stroup NE et al. CBTRUS statistical report:primary brain and central nervous system tumors diagnosed in the United States in 2005-2009[J]Neuro Oncol 201214Suppl 5(Suppl 5):v1-49. DOI: 10.1093/neuonc/nos218 .
返回引文位置Google Scholar
百度学术
万方数据
[12]
Ostrom QT , Gittleman H , Liao P et al. CBTRUS statistical report:primary brain and other central nervous system tumors diagnosed in the United States in 2010-2014[J]Neuro Oncol 201719(suppl 5):v1-v88. DOI: 10.1093/neuonc/nox158 .
返回引文位置Google Scholar
百度学术
万方数据
备注信息
A
谷伟军,Email: mocdef.3ab61103nujiewug
B
所有作者均声明不存在利益冲突
评论 (0条)
注册
登录
时间排序
暂无评论,发表第一条评论抢沙发
MedAI助手(体验版)
文档即答
智问智答
机器翻译
回答内容由人工智能生成,我社无法保证其准确性和完整性,该生成内容不代表我们的态度或观点,仅供参考。
生成快照
文献快照

你好,我可以帮助您更好的了解本文,请向我提问您关注的问题。

0/2000

《中华医学会杂志社用户协议》 | 《隐私政策》

《SparkDesk 用户协议》 | 《SparkDesk 隐私政策》

网信算备340104764864601230055号 | 网信算备340104726288401230013号

技术支持:

历史对话
本文全部
还没有聊天记录
设置
模式
纯净模式沉浸模式
字号